Betmiga 8 mg / ml Granules for prolonged-release oral suspension

Licence status
Authorised: 22/08/2024
Active substances
Mirabegron
Dosage Form
Prolonged-release granules for oral suspension
Licence number
EU/1/12/809/019-020
Licence holder
Astellas Pharma Europe B.V.

Product documents

Licence information

ATC code
G04BD12 mirabegron
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
22/08/2024